Irvine, Calif., - March 12, 2026 — BioDuro, a leading global contract research, development, and manufacturing organization (CRDMO), today announced the appointment of Andrew Thomas, Ph.D., and Stevan Djuric, Ph.D., as Scientific Advisors. In these new roles, they will provide strategic guidance to clients, and BioDuro's scientific and operational teams, helping strengthen the company's capabilities in innovative drug discovery and development.
Both advisors bring decades of global pharmaceutical R&D leadership experience and are already actively engaged in supporting BioDuro's customers' programs, applying their deep expertise to ensure the highest level of scientific excellence and service quality.
Dr. Thomas is an experienced pharmaceutical executive and entrepreneur with extensive leadership experience in medicinal chemistry. He previously served as Global Head of Medicinal Chemistry, Small Molecule Research at Roche, where he was a member of the company's Therapeutics Modalities Leadership Team, and led global teams responsible for advancing innovative drug discovery programs across multiple therapeutic areas.
Dr. Djuric is the former Vice President of Discovery Chemistry and Technology at AbbVie, where he led both the company's medicinal and discovery chemistry teams. With more than three decades of experience in pharmaceutical research, he has played a key role in advancing numerous drug discovery programs and has been widely recognized for his contributions to medicinal chemistry and innovation in drug discovery.
"We greatly value the insight and expertise provided by our scientific advisors," said Armin Spura, Ph.D., CEO of BioDuro. "Since BioDuro was founded 30 years ago, the company has striven to uphold the highest standards in science. The appointment of Drs. Thomas and Djuric deepens our commitment to scientific excellence and innovation as we continue to expand our capabilities and support our partners in advancing complex drug discovery programs."
About BioDuro
BioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, BioDuro employs more than 2,000 scientists with deep expertise in small- and large-molecule discovery, development, and manufacturing. We provide fully integrated drug discovery services spanning chemistry, biology, and pharmacokinetics (DMPK), along with comprehensive IND-enabling capabilities, including both drug substance and drug product development.
Media Enquiries
Christina Coby
Associate Director, Marketing, BioDuro
Email: christina.coby@bioduro.com
Mobile: +1 (619) 414 7409
Chris Halling
Director, Communications & Content, Orientation Marketing
Email: chris.halling@orientation.agency
Mobile: +44 (0)7580 041073
Home
